|
|
|
| Clinical effect of sclerotherapy with different administration methods of lauromacrogol under colonoscopy assisted by transparent cap in the treatment of stage I andⅡhemorrhagic internal hemorrhoids |
| QIN Guo-tao1 YANG Li1▲ DAI Chun-lei2 MA Wei-yan1 WANG Zhong-hui2 YANG Liu3 LIU Zhi-zhong1 |
1.Department of Gastroenterology,General Hospital of China First Automobile Works Group,Jilin Province,Changchun 130000,China;
2.Department of Hepatobiliary Surgery,General Hospital of China First Automobile Works Group,Jilin Province,Changchun 130000,China;
3.Department of General Surgery,General Hospital of China First Automobile Works Group,Jilin Province,Changchun 130000,China |
|
|
|
|
Abstract Objective To evaluate the efficacy and safety of sclerotherapy with different administration methods of lauromacrogol under transparent cap assisted colonoscopy in the treatment of stage I andⅡhemorrhagic internal hemorrhoids.Methods A total of 130 patients with stageⅠandⅡhemorrhagic internal hemorrhoids were selected as subjects from January 2019 to January 2020 in the Department of Gastroenterology in the General Hospital of China First Automobile Works Group,Jilin Province.The patients were divided into control group(75 cases)and observation group(55 cases)according to the order of admission time.The patients in the control group were divided into control group 1(stageⅠ,42 cases)and control group 2(stageⅡ,33 cases).The patients in the observation group were divided into observation group 1(stageⅠ,32 cases)and observation group 2(stageⅡ,23 cases).The control group 1 and control group 2 were treated with lauryl alcohol liquid sclerotherapy under colonoscopy assisted by transparent cap.The observation group 1 and the observation group 2 were treated with lauromacrogol foam sclerotherapy under colonoscopy assisted by transparent cap.The total dosage of lauryl alcohol,the total effective rate and the incidence of complications were compared.Results There was no significant difference in the total amount of lauromacrogol between the observation group 1 and the observation group 2(P＞0.05).The total amount of lauromacrogol in observation group 1 was less than control group 1,and the difference was statistically significant(P＜0.05).The total amount of lauromacrogol in observation group 2 was less than control group 2,and the difference was statistically significant(P＜0.05).There was no significant difference in the total effective rate between the observation group 1 and the control group 1(P＞0.05).There was no significant difference in the total effective rate between the observation group and the control group(P＞0.05).The total incidence of postoperative complications in observation group 1 was lower than control group 1,and the difference was statistically significant(P＜0.05).The total incidence of postoperative complications in observation group 2 was lower than control group 2,and the difference was statistically significant(P＜0.05).Conclusion Under colonoscopy assisted by transparent cap,the injection of lauromacrogol sclerosis agent is safe and effective in the treatment of stage I andⅡhemorrhagic internal hemorrhoids.Compared with liquid administration,foam administration of lauromacrogol has less dose and lower complication rate,which has obvious advantages.
|
|
|
|
|
|
| Cite this article: |
|
QIN Guo-tao,YANG Li,DAI Chun-lei, et al. Clinical effect of sclerotherapy with different administration methods of lauromacrogol under colonoscopy assisted by transparent cap in the treatment of stage I andⅡhemorrhagic internal hemorrhoids[J]. 中国当代医药, 2021, 28(14): 65-68.
|
|
|
|
| URL: |
| http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I14/65 |
| [1] |
邱仕平.痔疮的诊断与治疗[J].家庭医药，2019，（7）：29.
|
| [2] |
潘国宗，曹世植.现代胃肠病学[M].北京：科学出版社，1998：506.
|
| [3] |
Ahmad S.Efficacy of Percutaneous Sclerotherapy in Low Flow Venous Malformations-A Single Center Series[J].Neurointervention，2019，14（1）：53-60.
|
| [4] |
陆星华，程留芳.聚桂醇注射液临床经验总结[J].中国肛肠病学杂志，2014，13（4）：42
|
| [5] |
中华医学会外科学分会结直肠肛门外科学组.痔临床诊治指南（2006版）[J].中华胃肠外科杂志，2006，9（5）：461-463.
|
| [6] |
王永光.聚桂醇：新型的微创硬化治疗技术[J].微创医学，2011，6（1）：1-3
|
| [7] |
柯达.结肠镜下聚桂醇硬化注射术治疗Ⅱ、Ⅲ度内痔的研究[J].中外医学研究，2020，18（10）：5-7.
|
| [8] |
王峰，龚旭晨.聚桂醇硬化疗法治疗内痔出血的疗效和安全性[J]中国肛肠病杂志，2018，38（3）：30-32
|
| [9] |
Boregowda U，Umapathy C，Halim N，et al.Update on the management of gastrointestinal varices[J].World J Gastrointest Pharmacol Ther，2019，10（1）：1-21.
|
| [10] |
张婷，龙楚彦，崔伯塔，等.透明帽辅助内镜下硬化术治疗痔疮的前瞻性研究（含视频）[J].中华消化内镜杂志，2017，34（10）：709-712.
|
| [11] |
张艳，黄丽敏，董文佳，等.透明帽辅助肠镜下聚桂醇注射治疗Ⅰ-Ⅲ度内痔的临床疗效观察[J].中国保健营养，2020，30（21）：3-4，16.
|
| [12] |
陈颖，陈炜，方青青，等.透明帽辅助内镜下注射聚桂醇泡沫硬化剂治疗13例出血性内痔的临床观察[J].上海医药，2020，41（9）：17-22.
|
| [13] |
雷庆军，张毅强，贺向东.聚桂醇硬化剂注射术治疗出血性内痔疗效观察[J].现代中西医结合杂志，2017，26（10）：1116-1117.
|
| [14] |
沈峰，瞿春莹，张毅，等.肠镜下泡沫硬化剂治疗出血性内痔的疗效评估[J].中华消化内镜杂志，2019，36（12）：917-922.
|
| [15] |
Rubbini M，Ascanelli S.Classification and guidelines of hemorrhoidal disease：Present and future[J].World J Gastrointest Surg，2019，11（3）：117-121.
|
|
|
|
